INS and type 1 diabetes mellitus: When these cells were intraperitoneally implanted in mice with experimental type‐1 diabetes (T1D), intraperitoneal injection of a variety of chemicals regulated the production of sufficient insulin to maintain normoglycemia and reduce postprandial glycaemic excursions in the mice.